| 
		2021 | 
		Necessitats de les dones amb càncer de mama finalitzada la fase aguda del tractament: projecte de recerca qualitatiu | 
			
		
							Garcia Canovas, Marta
			
									 | 
	
	
	
		
									 		
		 | 
		2011 | 
		A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines | 
			
		
							Puig i Miquel, Teresa
			
			;					Aguilar, Helena
			
			;					Cufà González, SÃlvia
			
			;					Oliveras, Glòria
			
			;					Turrado, Carlos
			
			;					Ortega Gutiérrez, SÃlvia
			
			;					Benhamú, Bellinda
			
			;					López RodrÃguez, Maria Luz
			
			;					Urruticoechea, Ander
			
			;					Colomer, Ramon
			
									 | 
	
	
	
		
									 		
		 | 
		 | 
		A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines | 
			
		
							Puig i Miquel, Teresa
			
			;					Aguilar, Helena
			
			;					Cufà González, SÃlvia
			
			;					Oliveras, Glòria
			
			;					Turrado, Carlos
			
			;					Ortega Gutiérrez, SÃlvia
			
			;					Benhamú, Bellinda
			
			;					López RodrÃguez, Maria Luz
			
			;					Urruticoechea, Ander
			
			;					Colomer, Ramon
			
									 | 
	
	
	
		
									 		
		 | 
		 | 
		A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines | 
			
		
							Puig i Miquel, Teresa
			
			;					Aguilar, Helena
			
			;					Cufà González, SÃlvia
			
			;					Oliveras, Glòria
			
			;					Turrado, Carlos
			
			;					Ortega Gutiérrez, SÃlvia
			
			;					Benhamú, Bellinda
			
			;					López RodrÃguez, Maria Luz
			
			;					Urruticoechea, Ander
			
			;					Colomer, Ramon
			
									 | 
	
	
	
		
									 		
		 | 
		1 juny 2018 | 
		A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines | 
			
		
				
				 | 
	
	
	
		
									 		
		 | 
		5 juny 2018 | 
		A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines | 
			
		
							Puig i Miquel, Teresa
			
			;					Aguilar, Helena
			
			;					Cufà González, SÃlvia
			
			;					Oliveras, Glòria
			
			;					Turrado, Carlos
			
			;					Ortega Gutiérrez, SÃlvia
			
			;					Benhamú, Bellinda
			
			;					López RodrÃguez, Maria Luz
			
			;					Urruticoechea, Ander
			
			;					Colomer, Ramon
			
									 | 
	
	
	
		
									 		
		 | 
		 | 
		A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells | 
			
		
							Vert Company, Anna
			
			;					Castro Gallegos, Jessica
			
			;					Ribó i Panosa, Marc
			
			;					Benito i Mundet, Antoni
			
			;					Vilanova i Brugués, Maria
			
									 | 
	
	
	
		
									 		
		 | 
		 | 
		A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells | 
			
		
							Vert Company, Anna
			
			;					Castro Gallegos, Jessica
			
			;					Ribó i Panosa, Marc
			
			;					Benito i Mundet, Antoni
			
			;					Vilanova i Brugués, Maria
			
									 | 
	
	
	
		
									 		
		 | 
		1 juny 2018 | 
		A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells | 
			
		
				
				 | 
	
	
	
		
									 		
		 | 
		5 juny 2018 | 
		A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells | 
			
		
							Vert Company, Anna
			
			;					Castro Gallegos, Jessica
			
			;					Ribó i Panosa, Marc
			
			;					Benito i Mundet, Antoni
			
			;					Vilanova i Brugués, Maria
			
									 | 
	
	
	
		
									 		
		 | 
		2016 | 
		A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells | 
			
		
							Vert Company, Anna
			
			;					Castro Gallegos, Jessica
			
			;					Ribó i Panosa, Marc
			
			;					Benito i Mundet, Antoni
			
			;					Vilanova i Brugués, Maria
			
									 | 
	
	
	
		
									 		
		 | 
		 | 
		Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype | 
			
		
							Cuyàs, Elisabet
			
			;					Fernández Arroyo, Salvador
			
			;					Corominas Faja, Bruna
			
			;					RodrÃguez Gallego, Esther
			
			;					Bosch Barrera, Joaquim
			
			;					Martin Castillo, Begoña
			
			;					Llorens Duran, Rafael de
			
			;					Joven, Jorge
			
			;					Menéndez Menéndez, Javier Abel
			
									 | 
	
	
	
		
									 		
		 | 
		 | 
		Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype | 
			
		
							Cuyàs, Elisabet
			
			;					Fernández Arroyo, Salvador
			
			;					Corominas Faja, Bruna
			
			;					RodrÃguez Gallego, Esther
			
			;					Bosch Barrera, Joaquim
			
			;					Martin Castillo, Begoña
			
			;					Llorens Duran, Rafael de
			
			;					Joven, Jorge
			
			;					Menéndez Menéndez, Javier Abel
			
									 | 
	
	
	
		
									 		
		 | 
		1 juny 2018 | 
		Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype | 
			
		
				
				 | 
	
	
	
		
									 		
		 | 
		5 juny 2018 | 
		Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype | 
			
		
							Cuyàs, Elisabet
			
			;					Fernández Arroyo, Salvador
			
			;					Corominas Faja, Bruna
			
			;					RodrÃguez Gallego, Esther
			
			;					Bosch Barrera, Joaquim
			
			;					Martin Castillo, Begoña
			
			;					Llorens Duran, Rafael de
			
			;					Joven, Jorge
			
			;					Menéndez Menéndez, Javier Abel
			
									 | 
	
	
	
		
									 		
		 | 
		20 maig 2015 | 
		Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype | 
			
		
							Cuyàs, Elisabet
			
			;					Fernández Arroyo, Salvador
			
			;					Corominas Faja, Bruna
			
			;					RodrÃguez Gallego, Esther
			
			;					Bosch Barrera, Joaquim
			
			;					Martin Castillo, Begoña
			
			;					Llorens Duran, Rafael de
			
			;					Joven, Jorge
			
			;					Menéndez Menéndez, Javier Abel
			
									 | 
	
	
	
		
									 		
		 | 
		15 febrer 2020 | 
		Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype | 
			
		
							Cuyàs, Elisabet
			
			;					Fernández Arroyo, Salvador
			
			;					Corominas Faja, Bruna
			
			;					RodrÃguez Gallego, Esther
			
			;					Bosch Barrera, Joaquim
			
			;					Martin Castillo, Begoña
			
			;					Llorens Duran, Rafael de
			
			;					Joven, Jorge
			
			;					Menéndez Menéndez, Javier Abel
			
									 | 
	
	
	
		
									 		
		 | 
		 | 
		Paper jugat pel receptor ErbB-3 (HER-3) en el desenvolupament i tractament del càncer | 
			
		
							Cortés i Andrés, Adrià
			
									 | 
	
	
	
		
									 		
		 | 
		juny 2017 | 
		Paper jugat pel receptor ErbB-3 (HER-3) en el desenvolupament i tractament del càncer | 
			
		
							Cortés i Andrés, Adrià
			
									 | 
	
	
	
		
									 		
		 | 
		novembre 2022 | 
		Photodynamic therapy as an alternative to progestogens in endometrial cancer grade 1A G1: multicenter clinical analysis | 
			
		
							Bosch Solanes, Cristina
			
									 | 
	
	
	
		
									 		
		 | 
		 | 
		Preclinical evaluation of fatty acid synthase and egfrinhibition in triple-negative breast cancer | 
			
		
							Giró Perafita, Ariadna
			
			;					Palomeras, Sònia
			
			;					Lum, David H.
			
			;					Blancafort, Adriana
			
			;					Viñas, Gemma
			
			;					Oliveras, Glòria
			
			;					Perez Bueno, Ferran
			
			;					Sarrats Carbó, Ariadna
			
			;					Welm, Alana L.
			
			;					Puig i Miquel, Teresa
			
									 | 
	
	
	
		
									 		
		 | 
		 | 
		Preclinical evaluation of fatty acid synthase and egfrinhibition in triple-negative breast cancer | 
			
		
							Giró Perafita, Ariadna
			
			;					Palomeras, Sònia
			
			;					Lum, David H.
			
			;					Blancafort, Adriana
			
			;					Viñas, Gemma
			
			;					Oliveras, Glòria
			
			;					Perez Bueno, Ferran
			
			;					Sarrats Carbó, Ariadna
			
			;					Welm, Alana L.
			
			;					Puig i Miquel, Teresa
			
									 | 
	
	
	
		
									 		
		 | 
		1 juny 2018 | 
		Preclinical evaluation of fatty acid synthase and egfrinhibition in triple-negative breast cancer | 
			
		
				
				 | 
	
	
	
		
									 		
		 | 
		5 juny 2018 | 
		Preclinical evaluation of fatty acid synthase and egfrinhibition in triple-negative breast cancer | 
			
		
							Giró Perafita, Ariadna
			
			;					Palomeras, Sònia
			
			;					Lum, David H.
			
			;					Blancafort, Adriana
			
			;					Viñas, Gemma
			
			;					Oliveras, Glòria
			
			;					Perez Bueno, Ferran
			
			;					Sarrats Carbó, Ariadna
			
			;					Welm, Alana L.
			
			;					Puig i Miquel, Teresa
			
									 | 
	
	
	
		
									 		
		 | 
		15 setembre 2016 | 
		Preclinical evaluation of fatty acid synthase and egfrinhibition in triple-negative breast cancer | 
			
		
							Giró Perafita, Ariadna
			
			;					Palomeras Pairet, Sònia
			
			;					Lum, David H.
			
			;					Blancafort Jorquera, Adriana
			
			;					Viñas, Gemma
			
			;					Oliveras, Glòria
			
			;					Perez Bueno, Ferran
			
			;					Sarrats Carbó, Ariadna
			
			;					Welm, Alana L.
			
			;					Puig i Miquel, Teresa
			
									 |